Mingjiang Xu, Ph.D.
Professor
CTRC Council Distinguished Chair in Oncology
Currently seeking M.S. & Ph.D. students
My research aims to define whether and how specific changes in the epigenetic landscape are capable of influencing the initiation and progression of blood cancers and to identify the biochemical mediators involved in these processes. Our studies are expected to provide insights into cancer transcription regulation via DNA/RNA hydroxymethylation and long non-coding RNA (lncRNA)-mediated long-range chromosome interaction.
-
Professional Background
Education
- 2001 - Ph.D. - Developmental and Cell Biology - University of Tokyo
- 1994 - M.D. - Clinical Medicine - Shandong Univ. School of Medicine
Training
- 2003 - Postdoctoral Fellow - Molecular biology - Vanderbilt University
Appointments
- 2019- - Professor, Department of Molecular Medicine - The University of Texas Health Science Center at San Antonio
- 2019- - San Antonio Cancer Council Distinguished Chair in Oncology, Mays Cancer Center - The University of Texas Health Science Center at San Antonio
- 2015-2019 - Associate Professor, Department of Biochemistry and Molecular Biology, Sylvester Comprehensive Cancer Center - University of Miami Miller School of Medicine
- 2011-2015 - Associate Professor, Departments of Pediatrics, Herman B Wells Center for Pediatric Research - Indiana University School of Medicine
- 2007-2011 - Assistant Professor, Division of Hematology/Oncology, Department of Medicine, Tisch Cancer Institute - Mount Sinai School of Medicine
- 2004-2007 - Research Assistant Professor, Section of Hematology/Oncology, Department of Medicine - University of Illinois at Chicago
-
- Research & Grants
- Service
- Publications